group-II p-21-activated kinase inhibitors (Genentech)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namegroup-II p-21-activated kinase inhibitors (Genentech)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionP21-activated kinases inhibitors

TargetsP21-activated kinases

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A